Growth Metrics

Acadia Healthcare Company (ACHC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to 10.43%.

  • Acadia Healthcare Company's EBITDA Margin fell 87600.0% to 10.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.83%, marking a year-over-year decrease of 96400.0%. This contributed to the annual value of 1.61% for FY2024, which is 112300.0% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported EBITDA Margin of 10.43% as of Q3 2025, which was down 87600.0% from 9.71% recorded in Q2 2025.
  • Acadia Healthcare Company's EBITDA Margin's 5-year high stood at 3.79% during Q2 2022, with a 5-year trough of 52.17% in Q3 2023.
  • Its 5-year average for EBITDA Margin is 5.38%, with a median of 0.87% in 2022.
  • In the last 5 years, Acadia Healthcare Company's EBITDA Margin crashed by -533900bps in 2023 and then soared by 505100bps in 2024.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's EBITDA Margin stood at 2.87% in 2021, then plummeted by -130bps to 0.87% in 2022, then plummeted by -182bps to 2.44% in 2023, then plummeted by -322bps to 10.32% in 2024, then fell by -1bps to 10.43% in 2025.
  • Its EBITDA Margin stands at 10.43% for Q3 2025, versus 9.71% for Q2 2025 and 13.05% for Q1 2025.